Contact PD/PI: FIRESTEIN, GARY S OVERALL PROJECT ABSTRACT The UCSD Clinical and Translational Research Institute (CTRI) hub is located at the University of California, San Diego (UCSD). This regional center includes three universities (UCSD, San Diego State University and UC Riverside), 4 biomedical research institutes (Salk Institute, Sanford-Burnham-Prebys Medical Discovery Institute, J. Craig Venter Institute and La Jolla Institute for Immunology), 3 academic hospitals (UCSD Medical Center, VA San Diego Medical Center and Rady Children's Hospital), 2 community health centers (El Centro Medical Center and Eisenhower Medical Center) and multiple community agencies. The CTSA program encompasses 2 health sciences professional schools (Medicine, Pharmacy), 2 schools of public health (San Diego State University and UCSD), 2 Master's programs in Clinical Research and Drug Discovery Sciences and a new Translational Science Certificate. The program goals are to: 1) Develop an integrated education and training program across the translational science spectrum; 2) Empower community-based partnerships and team science while integrating stakeholders into translational research governance; 3) Diversify and enhance biomedical informatics infrastructure to provide secure, confidential and inter-operative platforms that are aligned with national CTSA standards; 4) Provide administrative infrastructure to manage and improve clinical and translational research; and 5) Provide resources that enhance collaboration, encourage disruptive innovation and support clinical investigation. The CTSA program, which is housed in the new Altman CTRI building, will provide the resources to develop the discipline of clinical and translational research, improve research quality and efficiency, assure a diverse workforce pipeline, and support a culture of collaboration and team science. The UCSD CTRI will incorporate UC Riverside School of Medicine and San Diego State University Schools of Nursing and Public Health into its KL2 program to increase the heterogeneity of disciplines and background of trainees. The Center for Life Course Research will support investigation across the lifespan and in special populations and support team science through a new Collaboration Core. We will develop two new team science centers called the Device Acceleration Center and the Center for Excellence in Translational Immunogenomics to facilitate engineer-clinician and basic scientist-clinician collaborations, respectively. The UCSD CTRI will leverage its resources by collaborating with other CTSA hubs, including the NCATS CTSA national centers and a consortium of University of California CTSA hubs. Page 126 Project Summary/Abstract Contact PD/PI: FIRESTEIN, GARY S OVERALL

Public Health Relevance

The UCSD Clinical and Translational Research Institute (CTRI) will continue to support and transform clinical research by providing guidance and support from initial planning of research through data analysis and dissemination. It will provide an educational pipeline to train the next generation of clinical and translational scientists and involve the community in setting the direction and priorities of the organization. The CTRI will foster development of novel technologies that facilitate clinical research and support investigators by providing the services needed to conduct clinical research and improve health. Page 127 Project Narrative

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
2UL1TR001442-06
Application #
10132439
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Brazhnik, Olga
Project Start
2015-08-13
Project End
2025-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Engineering (All Types)
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Remacle, Albert G; Dolkas, Jennifer; Angert, Mila et al. (2018) A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples. J Immunol Methods 455:80-87
Kalichman, Michael W; Plemmons, Dena K (2018) Intervention to Promote Responsible Conduct of Research Mentoring. Sci Eng Ethics 24:699-725
Africa, Jonathan A; Behling, Cynthia A; Brunt, Elizabeth M et al. (2018) In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. Clin Gastroenterol Hepatol 16:438-446.e1
Bernatchez, Jean A; Yang, Zunhua; Coste, Michael et al. (2018) Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus. Antimicrob Agents Chemother 62:
Goetz, Laura H; Schork, Nicholas J (2018) Personalized medicine: motivation, challenges, and progress. Fertil Steril 109:952-963
Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69
Limjoco, Jacqueline; Thornburg, Courtney D (2018) Risk factors for cardiovascular disease in children and young adults with haemophilia. Haemophilia 24:747-754
Liu, Chao; Guo, Theresa; Xu, Guorong et al. (2018) Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant. Clin Cancer Res 24:5123-5132
Sun, Heather Y; Proudfoot, James A; McCandless, Rachel T (2018) Prenatal detection of critical cardiac outflow tract anomalies remains suboptimal despite revised obstetrical imaging guidelines. Congenit Heart Dis 13:748-756
Bloss, Cinnamon S; Stoler, Justin; Schairer, Cynthia E et al. (2018) Characteristics Of Likely Precision Medicine Initiative Participants Drawn From A Large Blood Donor Population. Health Aff (Millwood) 37:786-792

Showing the most recent 10 out of 146 publications